Interactive Transcript
0:00
And this next video. I'd like to take a minute to talk about CAD rats.
0:04
What is CAD rats catarads is
0:07
one of these scoring systems that follows in
0:10
the tradition of other RADS types systems such as
0:13
bi-rads and Pirates. It's developed.
0:16
Of course by consensus of
0:19
multiple societies including
0:22
the American College of radiology American College
0:25
of Cardiology and some other societies
0:29
and basically it has been created to
0:32
develop a standardized method for reporting coronary
0:35
CT findings. It has been adopted by
0:38
many practices and it was originally published in 2016
0:41
and more recently updated just in 2022 up
0:44
to catarad's version 2.02 modification
0:48
added a couple things overall
0:51
plaque extent term called P1
0:54
through P4, which we'll talk about and then also an ischemia
0:57
modifier to reflect the development of we'll see
1:00
of fractional flow Reserve techniques that I'll talk
1:03
about as well. So just in general, you know,
1:06
should you use CAD RADS? I can't really answer that
1:09
question for you. I think it is helpful as
1:12
a standardized way of reporting and certainly if
1:15
you have multiple Radiologists reading that read things slightly
1:18
different way. It's a good way to achieve consistency across your
1:21
site. Do you have to use catarads? I
1:24
would say no.
1:25
there are some cardiologists out there who have worked
1:28
with who don't like catarads as much because of not
1:31
so much the disease categories, but rather the
1:34
recommendations for treatment that go with
1:37
them. Honestly, it probably comes down to a discussion with
1:40
you and your referring clinicians as to what what do you
1:43
think?
1:43
Is the best moving forward certainly?
1:46
Just using the catarads or a catarad's style.
1:49
Sort of reporting to lump patients into specific
1:52
categories is definitely useful for standardizing
1:55
the reporting across here your site
1:58
no matter how you do it.
2:00
So let's talk about the catarad score and basically
2:03
you're scoring the the patient 0 to
2:06
5. And this is the score based on the most severe stenosis
2:09
in the patient. So it's a per patient
2:12
score and the scores range from 0 no
2:15
disease.
2:16
One and two which are in the non obstructive minimal
2:19
and Mild disease categories. Then there's moderate disease
2:22
that gray area that we talked about in the last video on 50
2:25
to 69% stenosis.
2:27
And then severe disease which has two subheadings and
2:30
this is important. There's the 70% or
2:33
greater in one or two vessels which would be 4A or
2:36
4B which would be three vessels
2:39
70% or greater.
2:41
Or left main over 50% and why is
2:44
that a distinction that's made the main reason here is that patients
2:47
who are in the floor be category are actually
2:50
patients who may be best managed by
2:53
cabbage. And so those patients it may
2:56
be kind of a do not pass go situation where they need to go see the
2:59
surgeon and be evaluated or at least
3:02
get a cath to confirm these findings and then
3:05
be evaluated for potential surgery patients with
3:08
one to two severe stenoses the
3:11
management. There is a little Mercure
3:14
And it's really keeps evolving over time in the
3:17
past. I think the thought would have been that anybody with a severe
3:20
stenosis should really be evaluated for potential stenting and
3:23
revascularization. However, more recent
3:26
trials have shown that that may not be actually
3:29
needed in a lot of patience and medical therapy has
3:32
really shown to be just as successful in these
3:35
patients at least in improving mortality
3:38
and other nature cardiovascular outcomes
3:41
like a subsequent Mi heart attack
3:44
for instance and then cataracts five that's an inclusion
3:47
and non-diagnostic study.
3:50
So there are also other pieces to the cadread Schooler.
3:53
So you get a catarad score. Plus these other letters
3:56
that follow and the new one is
3:59
the plaque burden which is graded from
4:02
one to four one being mild to
4:05
being moderate three severe and for extensive they've actually
4:08
given us different ways to define the plaque
4:11
burden you can use a visual assessment. You can
4:14
do it from calcium score or you can
4:17
use this segmental involvement score. So the
4:20
calcium score you just look at the chart and whatever range your
4:23
calcium score falls into that's the number you give the patient P
4:26
1 through 4, so that's pretty simple.
4:29
The sis is the segmental involvement score. So
4:32
basically each coronary artery vessel segment
4:35
gets a score of 1 if they're involved with
4:38
any plaque of any kind. So a score
4:41
of three to four would mean that you may have the proximal and
4:44
mid LED and the proximal and mid-rca and
4:47
in that case you've got a score for
4:49
so it's actually doesn't take long to get you up to the severe level in
4:52
a lot of the patients that we see and then finally the
4:55
visual score they give you some information here about how to visually score
4:58
it. But basically it's a subjective assessment but
5:02
You know moderate amount would be one two vessels moderate out or
5:05
three with miles. So what is mild?
5:08
Meanwhile I'd say probably just one segment involved with vessel and
5:11
then it goes up from there.
5:13
What are the segments that we're talking about? Well, the coronary
5:16
artery segments have been defined by the Society of
5:19
cardiovascular CT and they have this guideline which
5:22
is widely available and they talk about the different segments
5:25
the corner arteries and basically you
5:28
have the left main is a segment approximal LED
5:31
is a segment middle. LED is a segment digital LEDs a
5:34
segment.
5:35
RCA proximal mid distal PDA,
5:38
you know, that's a segment the circumflex
5:41
proximal.
5:42
And then actually they lumped mid distal
5:45
into one segment for the circumflex and then each of
5:48
the major diagonal branches and obtuse marginal branches. And if you
5:51
have a ramus those are all segments as well. So basically, you know,
5:54
like I said, it doesn't take long to add up to quite a few segments with plaque When
5:57
you're counting up plaque severity.
5:59
Another thing that shows up in the cad
6:02
rats are these high-risk features and
6:05
Upstate? These are a bit controversial in terms
6:08
of it's not clearly known what to do with this high risk
6:11
plaque feature information and how it should affect management and that
6:14
that work is still being done. Some of this cadrad's information
6:17
is information that's going to be used to really
6:20
fuel future studies. That'll help us figure out how best
6:23
to use this information. But the idea behind these
6:26
high risk plaque features is that
6:28
There have been a lot of studies done where they take a look at patients who
6:31
end up having an acute coronary syndrome and
6:34
then they go back in time and look at what their coronary CT
6:37
was before they had this acute coronary syndrome. And when
6:40
you look at these patients, you'll find that these
6:43
particular features shown are more common in the
6:46
patients who end up going to acute coronary syndrome the problem
6:49
with the high risk plaque features. Unfortunately is that they're not very
6:52
specific you see these features and a lot
6:55
of patients and the vast majority of them will not go on to have acute coronary
6:58
syndrome. So that's where the question of how these will really
7:01
play into the patient management is still kind of a
7:04
little bit up in the air but hopefully more to come so as
7:07
we go through the different cases of
7:10
this course, I'm going to point out these features as we come across them.
7:13
But here's a review of the four features that are included
7:16
in the catarads.
7:18
So first, it's called spotty calcification and the idea
7:21
here is that you have a non calcified plaque, which
7:24
is this kind of lens shaped thing here and then within that
7:27
non calcified plaque, you've got a DOT of calcium in the
7:30
middle. That's spotty calcification.
7:33
Positive remodeling we talked about that already in the last
7:36
video. That's when the diameter of your vessel is
7:39
larger than the nearest normal segment because
7:42
the vessel has expanded to accommodate the plaque. And the
7:45
number here we think about is 1.1 a ratio of
7:48
1.1 of the level of the plaque compared to the normal
7:51
segment the napkin ring sign. This is honestly,
7:54
I think probably one of the tougher ones to see this and the low
7:57
attenuation plaque. This is actually when you look at a plaque
8:00
You see that you've got a low attenuation sort of
8:03
core of the plaque. Here's the Lumen. So
8:06
you've got this big non calcified plaque here. There's a low
8:09
attenuation area and surrounding that low attenuation area is
8:12
a brighter area, which is thought to be
8:15
an area of kind of enhancement of the rim of this plaque called
8:18
the napkin ring sign.
8:21
And then finally low attenuation plaque. That's a little more simple. That's where you get
8:24
non-calify plaque actually measures less than 30 ounce foot units these
8:27
two I would say are much more
8:30
rare to find. You know, when your day-to-day coronary
8:33
CT reading, whereas the top two, I'd say
8:36
are quite common when you're reading coronary c teams.
8:39
Other modifiers that are mentioned Within part of the catarad system
8:42
are listed here and you really would have
8:45
to refer to the whole cadres document to get all the
8:48
details. But basically there's also an addition
8:51
to non-diagnostic and high-risk black features we have ischemia
8:54
and that's to serve a yes/no stents. So
8:57
if you have a stent then you want to
9:00
you know mention that
9:01
Graft, let's say you have cabbage crafts.
9:04
Then your score should reflect the
9:07
patency of the graphed and the downstream
9:10
vessel beyond the graph the nestenosis your
9:13
score ignores any disease in the
9:16
native vessel, that's Upstream to the graph. So for instance, let's say
9:19
you have a LED occlusion. That's then
9:22
bypassed. You're not going to score the patient as a
9:25
you know, catarads five total occlusion. You're
9:28
gonna score them instead based on the patency
9:31
of the graph itself.
9:33
And then e is any sort of important coronary
9:36
findings that are not related to atherosclerosis such
9:39
as dissection aneurysmasculitis or something else along
9:42
those lines.
9:43
Just a quick note about ischemia and fractional
9:46
flow Reserve so ffr is something
9:49
that's come on to the scene in the past several years and as
9:52
generate a lot of excitement and the
9:55
idea here is that you take the anatomic information
9:58
about the coronaries and you
10:01
basically have these fancy computers with
10:04
high level processing power that segment out
10:07
the coronaries and based on the shape of the coronaries themselves.
10:10
They can actually calculate using these
10:13
computational fluid Dynamic approaches the
10:16
estimated flow across
10:19
the vessel in the various locations based on
10:22
the anatomy.
10:24
And it turns out that this actually holds up really well compared to
10:27
the gold standard which is actually sticking it down a catheter
10:30
in the patient and measuring the flow. And why
10:33
do we care about the flow? Well, the main reason we
10:36
care about the flow is that
10:37
We're interested in.
10:39
Whether or not there's a drop in flow across
10:42
the stenosis and the way that's measured by the
10:45
gold standard is this thing called the fractional flow reserve and
10:48
basically it's a ratio of the flow before and after
10:51
this stenosis and it tells us whether or not
10:54
there's a pressure drop across the stenosis.
10:57
And the amount of pressure drop that's important is a
11:00
pressure drop of 25% or greater.
11:03
So if your ffr is 0.75 that
11:06
means that you've had a 25% pressure drop that means
11:09
that you have a significance stenosis.
11:11
If your pressure drop is less than that if
11:14
it's less than 20% and that's consider not obstructive and
11:17
then there's this gray Zone which is somewhere between 25
11:20
and 20% pressure drop which is
11:23
considered indeterminate. So right now there is
11:26
a FDA approved third party vendor, which can do
11:29
this for you the way they have set up their system is
11:32
that you'll send out your coronary CT to their lab for processing and
11:35
then they'll send you back. The information afterwards folks are using
11:38
this basically to assess patients with
11:41
moderate disease and try to determine whether that moderate
11:44
disease is functionally significant or not. And sometimes
11:47
it can be surprising a plaque that looks really
11:50
severe on coronary CT on ffr analysis
11:53
may not be quite as severe. So it helps
11:56
guide and management and actually helps even more with
11:59
selecting patients who may need to go on to cardiac catheterization
12:02
and intervention and avoiding interventions
12:05
that aren't needed on patients who actually have ffr
12:08
which isn't in the obstructive.
12:12
Okay, and then my last slide on catarads is
12:16
just about the practice guidelines themselves and management
12:19
considerations that they
12:22
have Incorporated. So.
12:23
This is information within cataracts
12:26
says okay, if you have a catarads of you know, four what do
12:29
you do with the patient and it's a very busy slide
12:32
but basically the main thing you do and all these categories based
12:35
on some of the recent trial data is risk
12:38
factor modification and preventive pharmacotherapy. So
12:41
Optical medical management is in general recommended for
12:44
all these cases. Now, if you get into more severe
12:47
disease, you can consider catheterization and
12:51
revascularization if the symptoms persist after directed care
12:55
which in this case is usually medical management.
12:57
That's for those modern disease patients.
13:01
And then for those patients with severe disease.
13:03
Again, you want to do Optical medical management
13:06
and then consider other therapies
13:09
and revascularization per guidelines and the
13:12
guidelines, which is down here.
13:14
Would suggest that you could do some additional
13:17
Imaging or invasive coronary angiography.
13:20
If they're persistent symptoms, despite adequate medical
13:23
therapy. So a lot of this is getting back to
13:26
the fact that you know more recent trials have shown that
13:29
If you have a patient who has severe stenosis
13:32
that patient may not necessarily need to have
13:35
those stenosis opened up and revascularized that
13:38
Optical medical therapy can be just as effective
13:41
in a lot of those patients.
13:43
The one exception to that would be if patients have
13:46
severe Angel symptoms.
13:49
And that they don't improve with medical therapy. Then it is
13:52
recommended to go ahead and open up the stenosis and
13:55
revasclass those patients. So this is all within
13:58
the cataracts document and so it certainly
14:01
not expected that you remember any of this but just something to know
14:04
of as the next steps and what cadrads recommends
14:07
for our patients if we're using this
14:10
That sums up our cadrad's evaluation and
14:13
the next cases. We're going to move on to some real patient cases.